Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: NOVOGENE CORPORATION INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-08-09 to 2022-08-08
Current total value of award: $19400
Description: RNASEQ NEBNEXT ULTRA II (DIRECTIONAL) RNA WITH POLYA SELECTION NEXT GENERATION SEQUENCING ILLUMINA 2X150; 6GB ESTIMATED 40M PAIRED END READS (20M IN EACH DIRECTION) PER SAMPLE